RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Strap your boots CSE microcaps is the last place to find rational price action.
All the extractors are struggling. Valens doesn't consider it a significant source of revenue and transitioned out, Medipharms is a mess at 0.46, RTI is RTI, PULL is down to 0.33, Adastra is now Phyto, did a 3:1 reverse split and continues to fall. They're lumped in with these guys.
Nextleaf needs to catch a bid, get their story out now that it's working, demonstrate they're not falling into the same trappings as everyone else.